CARMAX INC
No SEC Form 4 filings for $KMX in the last 30 days.
See all $KMX insider activity →Morningstar says US-listed earnings are set to rise 44.6% in Q2 vs Q1, with 55% of reported stocks beating FactSet by at least 5%. It screens for undervalued “earnings crushers” meeting criteria and names six: ALB, TEAM, BAX, KMX, IONS, SNY, each with reported EPS and revenue vs consensus and discounts to fair value.
Morningstar says 55% of US-listed stocks it covers beat FactSet earnings by at least 5% as of Aug. 11. It screened for six undervalued “earnings crushers” with 10%+ EPS beats and 5%+ revenue beats, including Albemarle, Atlassian, Baxter International, CarMax, Ionis Pharmaceuticals, and Sanofi, citing EPS, revenue, Morningstar ratings, and discounts to fair value.
Carvana (CVNA) shares are down about 30% YTD in 2026 after below-consensus full-year adjusted EBITDA guidance, despite a record Q2 with $7.376B revenue and $769M adjusted EBITDA. CarMax (KMX) is up about 51% YTD on turnaround progress, including a Q1 FY2027 EPS beat and raised SG&A savings target. Analysts cut CVNA targets and upgraded KMX, with differing insider flows.
Over the past 7 days, alphai's AI scored 2 news stories mentioning KMX (CARMAX INC). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent KMX coverage spans financial news, sector analysis and market movers.
The earnings beat is offset by prior market skepticism around the new strategy, creating a potential re-assessment window.
The earnings beat is offset by market skepticism around strategy details, creating a two-sided setup.
KMX appears to be trading on turnaround execution and improved sales/pricing, with upside capped by already-strong rally and measured consensus.
Rating upgrade and higher target may reduce downside pressure and attract incremental dip-buying.
The filing discloses post-separation consulting terms and compensation structure, which can affect near-term sentiment but is not a fundamental earnings catalyst.
alphai scores every news story that mentions KMX with an AI model for sentiment and relevance, and aggregates insider trades from CARMAX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Morningstar says US-listed earnings are set to rise 44.6% in Q2 vs Q1, with 55% of reported stocks beating FactSet by at least 5%. It screens for undervalued “earnings crushers” meeting criteria and names six: ALB, TEAM, BAX, KMX, IONS, SNY, each with reported EPS and revenue vs consensus and discounts to fair value.
7 min readMorningstar says 55% of US-listed stocks it covers beat FactSet earnings by at least 5% as of Aug. 11. It screened for six undervalued “earnings crushers” with 10%+ EPS beats and 5%+ revenue beats, including Albemarle, Atlassian, Baxter International, CarMax, Ionis Pharmaceuticals, and Sanofi, citing EPS, revenue, Morningstar ratings, and discounts to fair value.
7 min readCarvana (CVNA) shares are down about 30% YTD in 2026 after below-consensus full-year adjusted EBITDA guidance, despite a record Q2 with $7.376B revenue and $769M adjusted EBITDA. CarMax (KMX) is up about 51% YTD on turnaround progress, including a Q1 FY2027 EPS beat and raised SG&A savings target. Analysts cut CVNA targets and upgraded KMX, with differing insider flows.
6 min readWall Street analyst calls covered Ford (F) upgraded to Buy at Citigroup with a $20 target, Caterpillar (CAT) cut to Neutral at Baird with a $900 target, and Reddit (RDDT) initiated as Overweight at KeyBanc with a $225 target. Other moves included Bloom Energy (BE) Buy at $290 and Texas Instruments (TXN) Buy at $405. Market context cited a Dow gain and lower oil.
7 min readCARMAX INC (KMX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.2 3 exhibit102-consultingagree.htm EX-10.2 Document Exhibit 10.2 CONSULTING AGREEMENT This Consulting Agreement (the “ Agreement ”) is made by and between CarMax, Inc. and its affiliated companies (collectively, the “Company”) and Diane L. Cafritz (the “Consultant”), effect
3 min readJPMorgan upgraded CarMax (KMX) to Neutral from Underweight and raised its price target to $60 from $38, citing stronger used-car sales trends and improved pricing that reduce near-term downside. JPMorgan expects low-double-digit comparable sales growth in fiscal Q3 and mid-single-digit for the year. CarMax’s fiscal Q1 revenue rose 6.2% to $8.01B, but comparable used-unit sales fell 0.8% and EPS fell 5.1% to $1.31.
5 min readWall Street analyst calls covered Ford, Caterpillar, Reddit, and Texas Instruments. Citigroup upgraded Ford to Buy. Baird cut Caterpillar to Neutral and lowered its target to $900. KeyBanc initiated Reddit at Overweight with a $225 level. Arete lifted Texas Instruments to Buy with a $405 target. Market recap cited strong Q2 earnings and lower oil prices.
3 min readCarMax (KMX) shares rose nearly 19% in June after its June 17 Q1 FY2027 results. Net revenue was just over $8B (+6% YoY) and GAAP net income fell 12% to $186M, or $1.31/share, beating consensus. Analysts raised price targets, including Stephens’ Jeff Lick to $66 from $43, and insiders bought shares.
6 min readCNBC’s “Stocks @ Night” previews Wednesday’s market drivers: Levi Strauss reports after the bell; SK Hynix’s U.S. listing is expected Friday, with EWY and SK Hynix weighting noted; auto retailers (CarMax, Carvana, Group 1) are highlighted; Costco monthly sales are due; energy and airline sectors are tracked; and Meta’s recent stock strength is mentioned.
2 min readChawla Sona purchased 2,000 shares of CARMAX INC (KMX) at $53.39 ($0.11M total) on 2026-06-25.
2 min read
